175 related articles for article (PubMed ID: 8588237)
1. Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.
Sehgal SN
Ther Drug Monit; 1995 Dec; 17(6):660-5. PubMed ID: 8588237
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of the immunosuppressant rapamycin.
Dumont FJ; Su Q
Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
[TBL] [Abstract][Full Text] [Related]
3. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.
Marx SO; Jayaraman T; Go LO; Marks AR
Circ Res; 1995 Mar; 76(3):412-7. PubMed ID: 7532117
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
6. Probing immunosuppressant action with a nonnatural immunophilin ligand.
Bierer BE; Somers PK; Wandless TJ; Burakoff SJ; Schreiber SL
Science; 1990 Oct; 250(4980):556-9. PubMed ID: 1700475
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin (sirolimus, rapamune).
Sehgal SN; Camardo JS; Scarola JA; Maida BT
Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):482-7. PubMed ID: 8591055
[TBL] [Abstract][Full Text] [Related]
8. Immunopharmacology of rapamycin.
Abraham RT; Wiederrecht GJ
Annu Rev Immunol; 1996; 14():483-510. PubMed ID: 8717522
[TBL] [Abstract][Full Text] [Related]
9. Neural roles of immunophilins and their ligands.
Sabatini DM; Lai MM; Snyder SH
Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
[TBL] [Abstract][Full Text] [Related]
10. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
[TBL] [Abstract][Full Text] [Related]
11. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
Heitman J; Movva NR; Hall MN
Science; 1991 Aug; 253(5022):905-9. PubMed ID: 1715094
[TBL] [Abstract][Full Text] [Related]
12. The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines.
Hultsch T; Martin R; Hohman RJ
Mol Biol Cell; 1992 Sep; 3(9):981-7. PubMed ID: 1384815
[TBL] [Abstract][Full Text] [Related]
13. Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription.
Hultsch T; Albers MW; Schreiber SL; Hohman RJ
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6229-33. PubMed ID: 1712484
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte chemotactic activity of FKBP and inhibition by FK506.
Leiva MC; Lyttle CR
Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
Schwaninger M; Blume R; Oetjen E; Knepel W
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
[TBL] [Abstract][Full Text] [Related]
16. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
17. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.
Sehgal SN
Clin Biochem; 1998 Jul; 31(5):335-40. PubMed ID: 9721431
[TBL] [Abstract][Full Text] [Related]
18. Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
Medh RD; Lay RH; Schmidt TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):11-23. PubMed ID: 9685211
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
[TBL] [Abstract][Full Text] [Related]
20. FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils.
Hom JT; Estridge T
Clin Immunol Immunopathol; 1993 Sep; 68(3):293-300. PubMed ID: 7690315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
